突发公告！董事长被立案调查

Core Viewpoint - The actual controller and chairman of Yong'an Pharmaceutical, Chen Yong, has been placed under investigation and detention by the Hefe County Supervisory Committee, as announced by the company on May 5 [2]. Company Overview - Yong'an Pharmaceutical was founded in 2001 and went public in March 2010. The company primarily engages in three business areas: research, production, and sales of taurine products; research, production, and sales of health foods; and research, production, and sales of special dietary foods (creatine) [6]. Recent Developments - The company has stated that it is unaware of the progress and conclusions regarding the investigation of Chen Yong and will continue to monitor the situation while adhering to relevant disclosure obligations [4][6]. - Despite the investigation, the company claims that its governance structure and internal control mechanisms are sound, and that other board members and senior management are performing their duties normally. The company's control has not changed, and its production and operational activities remain unaffected [6]. Financial Performance - In the first quarter of this year, the company reported revenue of 171 million yuan, a year-on-year decrease of 12.96%. The net loss attributable to the parent company was 4.3672 million yuan, a year-on-year increase of 115.23% [7]. Stock Market Activity - Prior to the May Day holiday, Yong'an Pharmaceutical's stock experienced significant volatility, recording five consecutive trading days of price increases from April 21 to April 29, with a total increase of nearly 60%. However, the stock closed at a limit down on April 30, at 12.91 yuan per share, with a market capitalization of 3.8 billion yuan [8].